University of Pittsburgh

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).

1,238 total trials 160 currently recruiting 917 completed early-phase tilt top decile by trial count

University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.

University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.

Top-decile sponsor footprint

University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 66/100

917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,238 total, page 14 of 25

COMPLETED NA

Optimizing Behavioral Health Homes for Adults With Serious Mental Illness

NCT02318797

COMPLETED NA

Vibrotactile Feedback During Vestibular Therapy

NCT02867683

COMPLETED

Leptin Receptors in the Bariatric Surgical Population Within the University of Pittsburgh Medical System: A Cohort Study

NCT02093416

TERMINATED NA

Same-day Dilapan-S With Adjunctive Misoprostol

NCT01818414

TERMINATED NA

Resistance and Cardiorespiratory Time-matched Exercise in Youth: A Randomized Clinical Trial (RCT:RCT)

NCT01938950

TERMINATED Phase 2

Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia

NCT01960387

TERMINATED NA

Gas Supply, Demand and Middle Ear Gas Balance -- Diagnosis of Eustachian Tube Dysfunction

NCT01974726

COMPLETED Phase 1

L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics

NCT01715844

COMPLETED Phase 2

Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.

NCT02185131

COMPLETED NA

4 Pillars Toolkit for Adolescent Vaccination

NCT02165722

COMPLETED

Quantification of Immune Cells in Women Using Contraception (CHIC II)

NCT01873170

COMPLETED NA

Functional Manifestations of Pressure Changes in the Middle Ear System

NCT01932736

COMPLETED NA

Vitamin D and Vascular Health in Children

NCT01797302

COMPLETED

The Impact of Vaginal and IM Progestins on the Cervix

NCT01954095

COMPLETED Phase 1

Vitamin D and Severe Asthma Exacerbations

NCT01921894

COMPLETED NA

Training Programs to Improve Outcomes for Individuals With Spinal Cord Injury

NCT01807728

COMPLETED Phase 1

Peri-operative Cefazolin Prophylaxis at Time of Cesarean Delivery in the Obese Gravida

NCT01904500

COMPLETED NA

Ultrasound-Assisted Paravertebral Block v. Traditional Paravertebral Block For Pain Control

NCT01949480

COMPLETED Phase 3

A Randomized Controlled Pilot Trial of Indomethacin in Acute Pancreatitis

NCT02692391

COMPLETED NA

Supportive Care Intervention-Pancreas

NCT01885884

COMPLETED Phase 1

The Surrogate Project (Surrogate Storytelling)

NCT01902784

COMPLETED Phase 1

Use of Ravicti™ in Patients With MCAD Deficiency With the 985A>G (K304E) Mutation

NCT01881984

COMPLETED

ECG Methods for the Prompt Identification of Coronary Events

NCT04237688

COMPLETED

Genomic Research in Alpha-1 Antitrypsin Deficiency

NCT01832220

COMPLETED NA

mHealth Skill Enhancement Plus Phone CBT for Type 2 Diabetes Distress Medication Nonadherence: Pilot Study

NCT02081586

COMPLETED

Genomic Research in Sarcoidosis

NCT01831739

COMPLETED NA

Attention Bias Modification for Transdiagnostic Anxiety

NCT02303691

COMPLETED NA

Structural Fat Grafting for Craniofacial Trauma: Repeat Fat Grafting Injection-5 Subject Cohort

NCT01822301

COMPLETED NA

SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM

NCT01868334

COMPLETED NA

Fat Grafting for Pedal Fat Pad Atrophy

NCT01796808

COMPLETED Phase 4

Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD

NCT01745848

COMPLETED NA

Functional Assessment Screening Patient Reported Information

NCT01669564

COMPLETED

Short Term Genetic Effects of Chemotherapy on Male Germ Cells

NCT02975245

COMPLETED NA

Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study

NCT02081573

COMPLETED NA

A Pilot Stress Management Intervention Study for High Risk Children With Asthma

NCT02091648

COMPLETED NA

Atrial Fibrillation Recurrence After Cryoballoon Ablation

NCT01772030

COMPLETED Phase 4

A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy

NCT01761019

COMPLETED NA

Feasibility of a Campaign Intervention Compared to a Standard Behavioral Weight Loss Intervention in Overweight and Obese Adults

NCT01803737

COMPLETED NA

Functional Brain Imaging of Pain Phenotype and Genotype

NCT01777087

COMPLETED

Assessment of Atrial Tissue Obtained From Patients Undergoing Heart Surgery and Tissue Banking

NCT01793623

COMPLETED

Surgical Prep in Hand Surgery

NCT01676051

COMPLETED

Clinical Meaning of Visual Analog Scales(VAS) for Teenage Pediatric Patients Undergoing Laparoscopic Surgical Procedures

NCT01755065

COMPLETED NA

A Text Message Behavioral Intervention to Reduce Alcohol Consumption in Young Adults

NCT01688245

TERMINATED

Eustachian Tube Function and Myringoplasty/Tympanoplasty

NCT01766856

COMPLETED NA

School Health Center Healthy Adolescent Relationship Program

NCT01678378

COMPLETED NA

The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease

NCT01687790

COMPLETED Phase 4

Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU

NCT01781299

COMPLETED

The Healing Context in CAM: Instrument Development and Initial Validation - Calibration Study

NCT01904838

COMPLETED

Longitudinal Lactation Bone Density Study

NCT01630629

COMPLETED NA

Examining Rehabilitation Training Methods

NCT02766400

← Previous Page 14 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 81
Phase 2 79
Phase 3 28
Phase 4 56

What is open in the University of Pittsburgh pipeline

160 recruiting of 1,238 indexed (13% open); 917 completed (74%).

Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).

Top condition: Depression (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Pittsburgh: open-pipeline peers nationwide

Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20%22% Total trials Recruiting share University of PittsburghNorthwestern UniversityEmory UniversityUniversity of Colorado, DenverAstraZenecaIntermountain Health CareMcMaster UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Temple University
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,238 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this University of Pittsburgh page

1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.

  • 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.